Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Versiani

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 28, 2003
A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia)M Versiani
International Journal of Psychiatry in Clinical Practice|June 14, 2014
The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant actionM Versiani
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patientsM Versiani
Journal of Affective Disorders|May 20, 1999
Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemideM Versiani
Current Therapeutic Research, Clinical and Experimental|January 1, 1977
A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophreniaJ Paprocki, M Versiani
Psychopharmacology Bulletin|April 1, 1977
A double-blind comparison between loxapine and chlordiazepoxide in the treatment of anxiety [proceedings]M Versiani, J Bueno, F Mundim
Journal of Clinical Psychopharmacology|February 1, 2000
Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorderM Versiani, M Amin, G Chouinard
International Clinical Psychopharmacology|July 1, 1997
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study GroupM Versiani, R Amrein, M Stabl
International Endodontic Journal|April 9, 2015
Methodological considerations on push-out tests in EndodonticsG De-Deus, E Souza, M Versiani
International Clinical Psychopharmacology|February 18, 1998
Social phobia: long-term treatment outcome and prediction of response--a moclobemide studyM Versiani, R Amrein, S A Montgomery
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 28, 2003
A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia)M Versiani
International Journal of Psychiatry in Clinical Practice|June 14, 2014
The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant actionM Versiani
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patientsM Versiani
Journal of Affective Disorders|May 20, 1999
Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemideM Versiani
Current Therapeutic Research, Clinical and Experimental|January 1, 1977
A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophreniaJ Paprocki, M Versiani
Psychopharmacology Bulletin|April 1, 1977
A double-blind comparison between loxapine and chlordiazepoxide in the treatment of anxiety [proceedings]M Versiani, J Bueno, F Mundim
Journal of Clinical Psychopharmacology|February 1, 2000
Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorderM Versiani, M Amin, G Chouinard
International Clinical Psychopharmacology|July 1, 1997
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study GroupM Versiani, R Amrein, M Stabl
International Endodontic Journal|April 9, 2015
Methodological considerations on push-out tests in EndodonticsG De-Deus, E Souza, M Versiani
International Clinical Psychopharmacology|February 18, 1998
Social phobia: long-term treatment outcome and prediction of response--a moclobemide studyM Versiani, R Amrein, S A Montgomery
Pageof 4